Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

184,005 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[A multicenter study of coronary artery disease and its risk factors in rheumatoid arthritis in China].
Li C, Wang XR, Tang YD, An Y, Zhou YS, Guo SW, Zhang XY, Duan TJ, Zhu JX, Li XF, Wang LZ, Wang CH, Wang YF, Yang R, Wang GC, Lu X, Zhu P, Chen LN, Jin HT, Liu JT, Liu XY, Sun L, Chen HY, Wei P, Wang JX, Cui LF, Shu R, Liu BL, Zhang ZL, Li GT, Li ZB, Yang J, Li JF, Jia B, Zhang FX, Tao JM, Han SL, Lin JY, Wei MQ, Liu XM, Ke D, Hu SX, Ye C, Yang XY, Li H, Huang CB, Gao M, Lai P, Li XF, Song LJ, Wang Y, Wang XY, Mu R, Su Y, Li ZG. Li C, et al. Among authors: zhang zl, zhang fx, zhang xy. Beijing Da Xue Xue Bao Yi Xue Ban. 2012 Apr 18;44(2):176-81. Beijing Da Xue Xue Bao Yi Xue Ban. 2012. PMID: 22516983 Free article. Chinese.
[Survey of tumor necrosis factor inhibitors application in patients with rheumatoid arthritis in China].
Wang XR, Su Y, An Y, Zhou YS, Zhang XY, Duan TJ, Zhu JX, Li XF, Wang CH, Wang LZ, Wang YF, Yang R, Wang GC, Lu X, Zhu P, Chen LN, Wang Y, Wang XY, Jin HT, Liu JT, Chen HY, Wei P, Wang JX, Liu XY, Sun L, Cui LF, Shu R, Liu BL, Zhang ZL, Li GT, Li ZB, Yang J, Li JF, Jia B, Zhang FX, Tao JM, Lin JY, Wei MQ, Liu XM, Ke D, Hu SX, Ye C, Han SL, Yang XY, Li H, Huang CB, Gao M, Lai P, Li XF, Song LJ, Mu R, Li ZG. Wang XR, et al. Among authors: zhang zl, zhang fx, zhang xy. Beijing Da Xue Xue Bao Yi Xue Ban. 2012 Apr 18;44(2):182-7. Beijing Da Xue Xue Bao Yi Xue Ban. 2012. PMID: 22516984 Free article. Chinese.
[Sulphasalazine in patients with rheumatoid arthritis in China: a cross-sectional study].
Liu T, Wang XR, An Y, Zhou YS, Zhang XY, Duan TJ, Zhu JX, Li XF, Wang LZ, Wang CH, Wang YF, Yang R, Wang GC, Lu X, Zhu P, Chen LN, Jin HT, Liu XY, Sun L, Chen HY, Cui LF, Shu R, Liu BL, Zhang ZL, Li GT, Li ZB, Yang J, Li JF, Jia B, Zhang FX, Tao JM, Han SL, Lin JY, Wei MQ, Liu XM, Ke D, Hu SX, Ye C, Yang XY, Li H, Huang CB, Gao M, Lai P, Li XF, Song LJ, Wang Y, Wang XY, Mu R, Su Y, Li ZG. Liu T, et al. Among authors: zhang zl, zhang fx, zhang xy. Beijing Da Xue Xue Bao Yi Xue Ban. 2012 Apr 18;44(2):188-94. Beijing Da Xue Xue Bao Yi Xue Ban. 2012. PMID: 22516985 Free article. Chinese.
Short-term and low-dose IL-2 therapy restores the Th17/Treg balance in the peripheral blood of patients with primary Sjögren's syndrome.
Miao M, Hao Z, Guo Y, Zhang X, Zhang S, Luo J, Zhao X, Zhang C, Liu X, Wu X, Xu D, Zhao J, Lu X, Gao C, Li X. Miao M, et al. Among authors: zhang s, zhang c, zhang x. Ann Rheum Dis. 2018 Dec;77(12):1838-1840. doi: 10.1136/annrheumdis-2018-213036. Epub 2018 Jun 23. Ann Rheum Dis. 2018. PMID: 29936436 No abstract available.
Disability and health-related quality of life in Chinese patients with rheumatoid arthritis: A cross-sectional study.
Zhou Y, Wang X, An Y, Zhang X, Han S, Li X, Wang L, Wang C, Wang Y, Yang R, Wang G, Lu X, Zhu P, Chen L, Liu J, Jin H, Liu X, Sun L, Wei P, Wang J, Chen H, Cui L, Shu R, Zhang Z, Li G, Li Z, Yang J, Li J, Jia B, Zhang F, Tao J, Lin J, Wei Q, Liu X, Ke D, Hu S, Ye C, Yang X, Li H, Huang C, Gao M, Li X, Song L, Wang Y, Wang X, Mu R, Su Y, Li Z. Zhou Y, et al. Among authors: zhang f, zhang z, zhang x. Int J Rheum Dis. 2018 Sep;21(9):1709-1715. doi: 10.1111/1756-185X.13345. Int J Rheum Dis. 2018. PMID: 30345647
Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial.
He J, Zhang R, Shao M, Zhao X, Miao M, Chen J, Liu J, Zhang X, Zhang X, Jin Y, Wang Y, Zhang S, Zhu L, Jacob A, Jia R, You X, Li X, Li C, Zhou Y, Yang Y, Ye H, Liu Y, Su Y, Shen N, Alexander J, Guo J, Ambrus J, Lin X, Yu D, Sun X, Li Z. He J, et al. Among authors: zhang r, zhang s, zhang x. Ann Rheum Dis. 2020 Jan;79(1):141-149. doi: 10.1136/annrheumdis-2019-215396. Epub 2019 Sep 19. Ann Rheum Dis. 2020. PMID: 31537547 Free PMC article. Clinical Trial.
184,005 results
You have reached the last available page of results. Please see the User Guide for more information.